In this regard, intraperitoneal curcumin at 150 mg/kg BW/day for four consecutive weeks has been shown to act as a PPARγ agonist in APP/PS1 mice, a transgenic mice model of AD that expressed elevated Aβ-protein level deposition [226]. The gene discussed is APP; the disease is Alzheimer disease.